Related Experiment Video
Updated: Mar 21, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
The Effect of HMG CoA Reductase Inhibitors on the Progression of Aortic Sclerosis: Review Article
Insights
Statin therapy for aortic stenosis shows conflicting results. Observational studies suggest benefits, but randomized controlled trials (RCTs) found no improvement, indicating insufficient evidence for current recommendations.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Aortic stenosis (AS) shares risk factors with arterial atherosclerosis.
- Statin therapy is being investigated for its potential to slow AS progression.
Purpose of the Study:
- To systematically review clinical trials on statin therapy and aortic stenosis progression.
- To investigate discrepancies in reported trial outcomes.
Main Methods:
- Systematic search and review of clinical trials.
- Analysis of 14 qualifying reports from 137 identified studies.
- Comparison of results from observational studies versus randomized controlled trials (RCTs).
Main Results:
- Eight of nine observational studies indicated statin therapy benefits for AS.
- All five randomized controlled trials (RCTs) reported no significant benefit of statin therapy on AS progression.
- Conflicting evidence exists regarding statin efficacy in aortic stenosis.
Conclusions:
- Insufficient evidence supports recommending statin treatment for aortic stenosis.
- Further research, potentially involving early-stage treatment or longer follow-up periods, is needed to definitively assess statin efficacy.
Abstract:
The risk factors and pathology for the development and progression of aortic stenosis are similar to those for arterial atherosclerosis. Statin therapy has been hypothesized to delay progression of aortic stenosis, but studies evaluating this hypothesis report conflicting results. We performed a systematic search and review of statin clinical trials of aortic stenosis progression to determine why there are apparent differences in trial results. We identified 137 reports related to clinical trials of statin therapy and aortic stenosis, 14 of which qualified for analysis. Eight of the nine observational studies reported benefit with statin therapy whereas all five randomized controlled trials (RCTs) reported no benefit. We conclude that there is insufficient evidence to recommend statin treatment for patients at risk of aortic stenosis. Treatment in early stages or studies with longer follow-up is required to conclusively evaluate this possibility.
